Manuela Grimstein

925 total citations · 1 hit paper
14 papers, 535 citations indexed

About

Manuela Grimstein is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Manuela Grimstein has authored 14 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Pediatrics, Perinatology and Child Health and 4 papers in Oncology. Recurrent topics in Manuela Grimstein's work include Pharmacogenetics and Drug Metabolism (6 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Pharmaceutical studies and practices (3 papers). Manuela Grimstein is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Pharmaceutical studies and practices (3 papers). Manuela Grimstein collaborates with scholars based in United States and Canada. Manuela Grimstein's co-authors include Shiew‐Mei Huang, Yuching Yang, Yaning Wang, Joseph A. Grillo, Xinyuan Zhang, Issam Zineh, Jianghong Fan, Hao‐Jie Zhu, Vikram Arya and Vikram Sinha and has published in prestigious journals such as Clinical Cancer Research, Journal of Pharmaceutical Sciences and Clinical Pharmacology & Therapeutics.

In The Last Decade

Manuela Grimstein

14 papers receiving 522 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Physiologically Based Pharmacokinetic Modeling in Regulatory Science: An Update From the U.S. Food and Drug Administration’s Office of Clinical Pharmacology

2018 241 citations Manuela Grimstein, Yuching Yang et al. Journal of Pharmaceutical Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manuela Grimstein United States	9	244	172	145	93	79	14	535
Juri Solodenko Germany	9	190 0.8×	206 1.2×	120 0.8×	121 1.3×	133 1.7×	14	709
Donato Teutonico France	12	185 0.8×	106 0.6×	111 0.8×	125 1.3×	89 1.1×	22	674
Nikolaos Tsamandouras United States	13	211 0.9×	96 0.6×	189 1.3×	177 1.9×	100 1.3×	20	874
Nam Atiqur Rahman United States	8	190 0.8×	114 0.7×	158 1.1×	114 1.2×	73 0.9×	18	609
Jingjing Yu United States	12	349 1.4×	198 1.2×	306 2.1×	160 1.7×	104 1.3×	23	852
Nassim Djebli France	14	155 0.6×	166 1.0×	158 1.1×	125 1.3×	77 1.0×	30	678
Eleanor Howgate United Kingdom	7	248 1.0×	85 0.5×	132 0.9×	73 0.8×	53 0.7×	10	415
K S Reynolds United States	6	290 1.2×	167 1.0×	273 1.9×	121 1.3×	87 1.1×	8	707
Howard Burt United Kingdom	12	337 1.4×	156 0.9×	306 2.1×	97 1.0×	65 0.8×	18	606

Countries citing papers authored by Manuela Grimstein

Since Specialization

Citations

This map shows the geographic impact of Manuela Grimstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Grimstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Grimstein more than expected).

Fields of papers citing papers by Manuela Grimstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Grimstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Grimstein. The network helps show where Manuela Grimstein may publish in the future.

Co-authorship network of co-authors of Manuela Grimstein

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Grimstein. A scholar is included among the top collaborators of Manuela Grimstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Grimstein. Manuela Grimstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Chow, Edwin C.Y., Alexei Ionan, Shwu‐Luan Lee, et al.. (2024). FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation. Clinical Cancer Research. 30(19). 4266–4271. 2 indexed citations

Yang, Xinxin, et al.. (2023). Utility of Physiologically Based Pharmacokinetic Modeling to Investigate the Impact of Physiological Changes of Pregnancy and Cancer on Oncology Drug Pharmacokinetics. Pharmaceutics. 15(12). 2727–2727. 5 indexed citations

Leong, Rupert W., et al.. (2023). Landscape and Regulatory Perspective on Oncology Drugs in Pregnancy. The Journal of Clinical Pharmacology. 63(S1). S170–S175. 1 indexed citations

Dinh, Jean, Trevor N. Johnson, Manuela Grimstein, & Tamorah Lewis. (2023). Physiologically Based Pharmacokinetics Modeling in the Neonatal Population—Current Advances, Challenges, and Opportunities. Pharmaceutics. 15(11). 2579–2579. 7 indexed citations

Kasamon, Yvette L., Elyes Dahmane, Yuching Yang, et al.. (2023). FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma. Clinical Cancer Research. 30(1). 17–22. 17 indexed citations

Zhang, Xinyuan, Yuching Yang, Manuela Grimstein, et al.. (2021). Anti–SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology Considerations. CPT Pharmacometrics & Systems Pharmacology. 10(9). 973–982. 13 indexed citations

Grimstein, Manuela, Hari Cheryl Sachs, Mark Mirochnick, et al.. (2021). Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development. Frontiers in Pediatrics. 9. 721059–721059. 8 indexed citations

Fan, Jianghong, Yuching Yang, Manuela Grimstein, et al.. (2021). Whole Body PBPK Modeling of Remdesivir and Its Metabolites to Aid in Estimating Active Metabolite Exposure in the Lung and Liver in Patients With Organ Dysfunction. Clinical Pharmacology & Therapeutics. 111(3). 624–634. 16 indexed citations

Fan, Jianghong, Xinyuan Zhang, Youwei Bi, et al.. (2021). Model‐Informed Drug Development Approaches to Assist New Drug Development in the COVID‐19 Pandemic. Clinical Pharmacology & Therapeutics. 111(3). 572–578. 9 indexed citations

10.

Yang, Yuching, Xinyuan Zhang, Jianghong Fan, et al.. (2021). Usage of In Vitro Metabolism Data for Drug‐Drug Interaction in Physiologically Based Pharmacokinetic Analysis Submissions to the US Food and Drug Administration. The Journal of Clinical Pharmacology. 61(6). 782–788. 12 indexed citations

11.

Zhang, Xinyuan, Yuching Yang, Manuela Grimstein, et al.. (2020). Application of PBPK Modeling and Simulation for Regulatory Decision Making and Its Impact on US Prescribing Information: An Update on the 2018‐2019 Submissions to the US FDA's Office of Clinical Pharmacology. The Journal of Clinical Pharmacology. 60(S1). S160–S178. 138 indexed citations

12.

Grimstein, Manuela & Shiew‐Mei Huang. (2018). A regulatory science viewpoint on botanical–drug interactions. Journal of Food and Drug Analysis. 26(2). S12–S25. 27 indexed citations

13.

Grimstein, Manuela, Yuching Yang, Xinyuan Zhang, et al.. (2018). Physiologically Based Pharmacokinetic Modeling in Regulatory Science: An Update From the U.S. Food and Drug Administration’s Office of Clinical Pharmacology. Journal of Pharmaceutical Sciences. 108(1). 21–25. 241 indexed citations breakdown →

14.

Pan, Yuzhuo, Vicky Hsu, Manuela Grimstein, et al.. (2016). The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives. The Journal of Clinical Pharmacology. 56(S7). S122–31. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact